Skip to main content
Erschienen in: Pediatric Cardiology 7/2022

02.04.2022 | Original Article

Frequency of QTc Interval Prolongation in Children and Adults with Williams Syndrome

verfasst von: Benjamin D. Brink, Richard Feinn, Beth A. Kozel, Charles J. Billington Jr, Delong Liu, Eric Yu, Sampat Sindhar, Julie He, Charles Rouse, Rachel Lampert, Barbara R. Pober, Robert W. Elder

Erschienen in: Pediatric Cardiology | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

QTc prolongation (≥ 460 ms), according to Bazett formula (QTcB), has been identified to be increased in Williams syndrome (WS) and suggested as a potential cause of increased risk of sudden cardiac death. The Bazett formula tends to overestimate QTc in higher heart rates. We performed a retrospective chart review of WS patients with ≥ 1 electrocardiogram (EKG) with sinus rhythm, no evidence of bundle branch blocks, and measurable intervals. A total of 280 EKGs from 147 patients with WS were analyzed and 123 EKGs from 123 controls. The QTc was calculated using Bazett formula. The average QTcB for individuals with WS and controls was 444 ± 24 ms and 417 ± 26 ms, respectively (p < 0.001). In our WS cohort 34.4% had at least 1 EKG with a QTcB ≥ 460 ms. The mean heart rate (HR) from patients with WS was significantly higher than controls (96 bpm vs 76 bpm, p < 0.001). Linear regression showed that HR contributed 27% to QTcB prolongation in the patients with WS. Patients with WS have a mean QTcB in the normal range but higher than controls, and a higher than expected frequency of QTc ≥ 460 ms compared to the general population. HR is also higher in WS and contributes modestly to the WS QTcB prolongation. Future studies are needed to assess if these findings contribute risk to sudden cardiac death but in the interim we recommend routine EKG testing, especially when starting QTc prolonging medications.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Collins RT 2nd (2013) Cardiovascular disease in Williams syndrome. Circulation 127:2125–2134CrossRef Collins RT 2nd (2013) Cardiovascular disease in Williams syndrome. Circulation 127:2125–2134CrossRef
2.
Zurück zum Zitat Williams JC, Barratt-Boyes BG, Lowe JB (1961) Supravalvular aortic stenosis. Circulation 24:1311–1318CrossRef Williams JC, Barratt-Boyes BG, Lowe JB (1961) Supravalvular aortic stenosis. Circulation 24:1311–1318CrossRef
3.
Zurück zum Zitat Kaplan P, Wang PP, Francke U (2001) Williams (Williams Beuren) syndrome: a distinct neurobehavioral disorder. J Child Neurol 16:177–190CrossRef Kaplan P, Wang PP, Francke U (2001) Williams (Williams Beuren) syndrome: a distinct neurobehavioral disorder. J Child Neurol 16:177–190CrossRef
4.
Zurück zum Zitat Wessel A, Gravenhorst V, Buchhorn R, Gosch A, Partsch CJ, Pankau R (2004) Risk of sudden death in the Williams-Beuren syndrome. Am J Med Genet A 127a: 234–237 Wessel A, Gravenhorst V, Buchhorn R, Gosch A, Partsch CJ, Pankau R (2004) Risk of sudden death in the Williams-Beuren syndrome. Am J Med Genet A 127a: 234–237
5.
Zurück zum Zitat Collins RT 2nd, Aziz PF, Gleason MM, Kaplan PB, Shah MJ (2010) Abnormalities of cardiac repolarization in Williams syndrome. Am J Cardiol 106:1029–1033CrossRef Collins RT 2nd, Aziz PF, Gleason MM, Kaplan PB, Shah MJ (2010) Abnormalities of cardiac repolarization in Williams syndrome. Am J Cardiol 106:1029–1033CrossRef
6.
Zurück zum Zitat Taggart NW, Haglund CM, Tester DJ, Ackerman MJ (2007) Diagnostic miscues in congenital long-QT syndrome. Circulation 115:2613–2620CrossRef Taggart NW, Haglund CM, Tester DJ, Ackerman MJ (2007) Diagnostic miscues in congenital long-QT syndrome. Circulation 115:2613–2620CrossRef
7.
Zurück zum Zitat Mazzanti A, Maragna R, Vacanti G, Monteforte N, Bloise R, Marino M, Braghieri L, Gambelli P, Memmi M, Pagan E, Morini M, Malovini A, Ortiz M, Sacilotto L, Bellazzi R, Monserrat L, Napolitano C, Bagnardi V, Priori SG (2018) Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome. J Am Coll Cardiol 71:1663–1671CrossRef Mazzanti A, Maragna R, Vacanti G, Monteforte N, Bloise R, Marino M, Braghieri L, Gambelli P, Memmi M, Pagan E, Morini M, Malovini A, Ortiz M, Sacilotto L, Bellazzi R, Monserrat L, Napolitano C, Bagnardi V, Priori SG (2018) Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome. J Am Coll Cardiol 71:1663–1671CrossRef
8.
Zurück zum Zitat Collins RT 2nd, Kaplan P, Somes GW, Rome JJ (2010) Long-term outcomes of patients with cardiovascular abnormalities and williams syndrome. Am J Cardiol 105:874–878CrossRef Collins RT 2nd, Kaplan P, Somes GW, Rome JJ (2010) Long-term outcomes of patients with cardiovascular abnormalities and williams syndrome. Am J Cardiol 105:874–878CrossRef
9.
Zurück zum Zitat Kim SS, Ko SM, Choi SI, Choi BH, Stillman AE (2016) Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance. Int J Cardiovasc Imaging 32(Suppl 1):21–43CrossRef Kim SS, Ko SM, Choi SI, Choi BH, Stillman AE (2016) Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance. Int J Cardiovasc Imaging 32(Suppl 1):21–43CrossRef
10.
Zurück zum Zitat Collins RT 2nd, Kaplan P, Somes GW, Rome JJ (2010) Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome. J Pediatr 156:253-258.e251CrossRef Collins RT 2nd, Kaplan P, Somes GW, Rome JJ (2010) Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome. J Pediatr 156:253-258.e251CrossRef
11.
Zurück zum Zitat McCarty HM, Tang X, Swearingen CJ, Collins RT 2nd (2013) Comparison of electrocardiographic QTc duration in patients with supravalvar aortic stenosis with versus without Williams syndrome. Am J Cardiol 111:1501–1504CrossRef McCarty HM, Tang X, Swearingen CJ, Collins RT 2nd (2013) Comparison of electrocardiographic QTc duration in patients with supravalvar aortic stenosis with versus without Williams syndrome. Am J Cardiol 111:1501–1504CrossRef
12.
Zurück zum Zitat Keating MT (1995) Genetic approaches to cardiovascular disease. Supravalvular aortic stenosis, Williams syndrome, and long-QT syndrome. Circulation 92:142–147CrossRef Keating MT (1995) Genetic approaches to cardiovascular disease. Supravalvular aortic stenosis, Williams syndrome, and long-QT syndrome. Circulation 92:142–147CrossRef
13.
Zurück zum Zitat Burch TM, McGowan FX Jr, Kussman BD, Powell AJ, DiNardo JA (2008) Congenital supravalvular aortic stenosis and sudden death associated with anesthesia: what’s the mystery? Anesth Analg 107:1848–1854CrossRef Burch TM, McGowan FX Jr, Kussman BD, Powell AJ, DiNardo JA (2008) Congenital supravalvular aortic stenosis and sudden death associated with anesthesia: what’s the mystery? Anesth Analg 107:1848–1854CrossRef
14.
Zurück zum Zitat Pham PP, Moller JH, Hills C, Larson V, Pyles L (2009) Cardiac catheterization and operative outcomes from a multicenter consortium for children with williams syndrome. Pediatr Cardiol 30:9–14CrossRef Pham PP, Moller JH, Hills C, Larson V, Pyles L (2009) Cardiac catheterization and operative outcomes from a multicenter consortium for children with williams syndrome. Pediatr Cardiol 30:9–14CrossRef
15.
Zurück zum Zitat Bird LM, Billman GF, Lacro RV, Spicer RL, Jariwala LK, Hoyme HE, Zamora-Salinas R, Morris C, Viskochil D, Frikke MJ, Jones MC (1996) Sudden death in Williams syndrome: report of ten cases. J Pediatr 129:926–931CrossRef Bird LM, Billman GF, Lacro RV, Spicer RL, Jariwala LK, Hoyme HE, Zamora-Salinas R, Morris C, Viskochil D, Frikke MJ, Jones MC (1996) Sudden death in Williams syndrome: report of ten cases. J Pediatr 129:926–931CrossRef
16.
Zurück zum Zitat Chockalingam P, Crotti L, Girardengo G, Johnson JN, Harris KM, van der Heijden JF, Hauer RN, Beckmann BM, Spazzolini C, Rordorf R, Rydberg A, Clur SA, Fischer M, van den Heuvel F, Kääb S, Blom NA, Ackerman MJ, Schwartz PJ, Wilde AA (2012) Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol 60:2092–2099CrossRef Chockalingam P, Crotti L, Girardengo G, Johnson JN, Harris KM, van der Heijden JF, Hauer RN, Beckmann BM, Spazzolini C, Rordorf R, Rydberg A, Clur SA, Fischer M, van den Heuvel F, Kääb S, Blom NA, Ackerman MJ, Schwartz PJ, Wilde AA (2012) Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol 60:2092–2099CrossRef
17.
Zurück zum Zitat Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, Ector J, Willems R (2016) Which QT correction formulae to use for QT monitoring? J Am Heart Assoc 5 Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, Ector J, Willems R (2016) Which QT correction formulae to use for QT monitoring? J Am Heart Assoc 5
18.
Zurück zum Zitat Parrish PCR, Liu D, Knutsen RH, Billington CJ, Mecham RP, Fu YP, Kozel BA (2020) Whole exome sequencing in patients with Williams-Beuren syndrome followed by disease modeling in mice points to four novel pathways that may modify stenosis risk. Hum Mol Genet 29:2035–2050CrossRef Parrish PCR, Liu D, Knutsen RH, Billington CJ, Mecham RP, Fu YP, Kozel BA (2020) Whole exome sequencing in patients with Williams-Beuren syndrome followed by disease modeling in mice points to four novel pathways that may modify stenosis risk. Hum Mol Genet 29:2035–2050CrossRef
19.
Zurück zum Zitat Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRef Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRef
20.
Zurück zum Zitat Hayes AF (2017) Introduction to mediation, moderation, and conditional process analysis: a regression-based approach, 2nd edn. The Guilford Press Hayes AF (2017) Introduction to mediation, moderation, and conditional process analysis: a regression-based approach, 2nd edn. The Guilford Press
21.
22.
Zurück zum Zitat Nachimuthu S, Assar MD, Schussler JM (2012) Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf 3:241–253CrossRef Nachimuthu S, Assar MD, Schussler JM (2012) Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf 3:241–253CrossRef
23.
Zurück zum Zitat Luo S, Michler K, Johnston P, Macfarlane PW (2004) A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 37(Suppl):81–90CrossRef Luo S, Michler K, Johnston P, Macfarlane PW (2004) A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 37(Suppl):81–90CrossRef
24.
Zurück zum Zitat Johnson JN, Ackerman MJ (2009) QTc: how long is too long? Br J Sports Med 43:657–662CrossRef Johnson JN, Ackerman MJ (2009) QTc: how long is too long? Br J Sports Med 43:657–662CrossRef
25.
Zurück zum Zitat Gueta I, Klempfner R, Markovits N, Halkin H, Segev S, Rott D, Peled Y, Loebstein R (2020) Clinically significant incidental QTc prolongation is subject to within-individual variability. Ann Noninvasive Electrocardiol 25:e12699CrossRef Gueta I, Klempfner R, Markovits N, Halkin H, Segev S, Rott D, Peled Y, Loebstein R (2020) Clinically significant incidental QTc prolongation is subject to within-individual variability. Ann Noninvasive Electrocardiol 25:e12699CrossRef
26.
Zurück zum Zitat Kallergis EM, Goudis CA, Simantirakis EN, Kochiadakis GE, Vardas PE (2012) Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. Sci World J 212178 Kallergis EM, Goudis CA, Simantirakis EN, Kochiadakis GE, Vardas PE (2012) Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. Sci World J 212178
27.
Zurück zum Zitat Roden DM, Viswanathan PC (2005) Genetics of acquired long QT syndrome. J Clin Invest 115:2025–2032CrossRef Roden DM, Viswanathan PC (2005) Genetics of acquired long QT syndrome. J Clin Invest 115:2025–2032CrossRef
28.
Zurück zum Zitat Prasad S, Furr AJ, Zhang S, Ball S, Allen AJ (2007) Baseline values from the electrocardiograms of children and adolescents with ADHD. Child Adolesc Psychiatry Ment Health 1:11CrossRef Prasad S, Furr AJ, Zhang S, Ball S, Allen AJ (2007) Baseline values from the electrocardiograms of children and adolescents with ADHD. Child Adolesc Psychiatry Ment Health 1:11CrossRef
29.
Zurück zum Zitat Frederiksen TC, Christiansen MK, Charmoth Østergaard P, Hove Thomsen P, Graff C, Clausen L, Kjærulf Jensen H (2018) QTc interval and risk of cardiac events in adults with anorexia nervosa: a long-term follow-up study. Circ Arrhythm Electrophysiol 11:e005995CrossRef Frederiksen TC, Christiansen MK, Charmoth Østergaard P, Hove Thomsen P, Graff C, Clausen L, Kjærulf Jensen H (2018) QTc interval and risk of cardiac events in adults with anorexia nervosa: a long-term follow-up study. Circ Arrhythm Electrophysiol 11:e005995CrossRef
Metadaten
Titel
Frequency of QTc Interval Prolongation in Children and Adults with Williams Syndrome
verfasst von
Benjamin D. Brink
Richard Feinn
Beth A. Kozel
Charles J. Billington Jr
Delong Liu
Eric Yu
Sampat Sindhar
Julie He
Charles Rouse
Rachel Lampert
Barbara R. Pober
Robert W. Elder
Publikationsdatum
02.04.2022
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2022
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-022-02883-3

Weitere Artikel der Ausgabe 7/2022

Pediatric Cardiology 7/2022 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.